# Anita D"Souza, M.D. – FDA Inspection, Feb 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/anita-dsouza-md/97148749-8ec7-44d3-a4bf-ae68cbe00c43
Source feed: FDA_Inspections

> FDA inspection 1230064 of Anita D"Souza, M.D., February 16, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230064
- Company Name: Anita D"Souza, M.D.
- Inspection Date: 2024-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/denise-l-burosh/075a442f-67e0-4a65-9c09-e8819a329773)

Company: https://www.keypedia.com/companies/anita-dsouza-md/52c78455-4100-4d28-8bfe-1e81cd1c16e3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c